TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding TFF Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 51 | 43 | −8 |
| Shares | 4.64M | 4.30M | −339.8K (−7.3%) |
| Value | $41.1M | $27.1M | −$14.0M (−34.1%) |
New holders (1)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Selective Wealth Management, Inc. | 2,500 | $16.0K | 0.01% |
Sold out (9)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| MYDA Advisors LLC | 40,000 | $355.0K |
| IndexIQ Advisors LLC | 31,121 | $276.0K |
| Aristides Capital LLC | 13,653 | $121.0K |
| Goldman Sachs Group Inc | 13,342 | $118.0K |
| Jane Street Group, LLC | 10,058 | $89.0K |
| Caption Management, LLC | 2,238 | $20.0K |
| Aquatic Capital Management LLC | 1,600 | $14.0K |
| Citigroup Inc | 913 | $8.00K |
| Gemmer Asset Management LLC | 500 | $4.00K |